Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19
Genevieve Rocheleau, Terry Lee, Yassene Mohammed, et al.
Critical Care Medicine (2022)
Open Access | Times Cited: 21

Showing 21 citing articles:

Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment
Mark C. Chappell
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1320-1337
Open Access | Times Cited: 17
Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia
Chel Hee Lee, Mohammad Mehdi Banoei, Mariam Ansari, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 5
Gender differences in sequelae from COVID-19 infection
Trinity Eimer, Sonia Villapol
Elsevier eBooks (2025), pp. 599-613
Closed Access
Angiotensin-Converting Enzyme Inhibition as a Potential Risk Factor for Periprosthetic Joint Infection Following Total Knee Arthroplasty
Rishi Trikha, Nicolas Cevallos, Alan L. Zhang, et al.
Arthroplasty Today (2025) Vol. 32, pp. 101641-101641
Closed Access
Effects of Losartan on Patients Hospitalized for Acute Coronavirus Disease 2019: A Randomized Controlled Trial
Karen Tran, Pierre Asfar, Matthew P. Cheng, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 3, pp. 615-625
Closed Access | Times Cited: 3
Mini-review: Angiotensin- converting enzyme 1 (ACE1) and the impact for diseases such as Alzheimer’s disease, sarcopenia, cancer, and COVID-19
Valquíria Bueno, Daniela Frasca
Frontiers in Aging (2023) Vol. 4
Open Access | Times Cited: 8
COVID-19 and cardiovascular disease in patients with chronic kidney disease
Lucia Del Vecchio, Olga Balafa, Evangelia Dounousi, et al.
Nephrology Dialysis Transplantation (2023) Vol. 39, Iss. 2, pp. 177-189
Open Access | Times Cited: 8
Biological sex differences in renin angiotensin system enzymes ACE and ACE2 regulate normal tissue response to radiation injury
Guru Prasad Sharma, Anne Frei, Brian L. Fish, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 7
Angiotensin-Converting Enzyme (ACE) level, but not ACE gene polymorphism, is associated with prognosis of COVID-19 infection: Implications for diabetes and hypertension
Onur Elbasan, Feyza Bayram, Ceyda Dinçer Yazan, et al.
PLoS ONE (2023) Vol. 18, Iss. 7, pp. e0288338-e0288338
Open Access | Times Cited: 7
Association between blood pressure and COVID-19 severity
Fumiki Yoshihara
Hypertension Research (2023) Vol. 47, Iss. 3, pp. 683-684
Open Access | Times Cited: 2
Vasopressor Responsiveness 101: Prediction of Responsiveness to Angiotensin II Infusion*
James A. Russell
Critical Care Medicine (2024) Vol. 52, Iss. 8, pp. 1310-1313
Closed Access
Community versus academic hospital community-acquired pneumonia patients: a nested cohort study
Jennifer Tsang, Kian Rego, Alexandra Binnie, et al.
Pneumonia (2024) Vol. 16, Iss. 1
Open Access
Complex Thrombo-Inflammatory Responses versus Outcomes of Non-COVID-19 Community-Acquired Pneumonia and COVID-19
Greg Haljan, Terry Lee, Anne McCarthy, et al.
Journal of Innate Immunity (2024) Vol. 16, Iss. 1, pp. 529-552
Closed Access
Insertion/deletion (I/D) polymorphisms of angiotensin-converting enzyme gene and their implications for susceptibility and severity of COVID-19: A systematic review and meta-analysis
Jonny Karunia Fajar, Fredo Tamara, Wachid Putranto, et al.
Narra J (2024) Vol. 4, Iss. 3, pp. e727-e727
Closed Access
Renin as a Prognostic and Predictive Biomarker in Sepsis: More Questions Than Answers?*
Emily See, James A. Russell, Rinaldo Bellomo, et al.
Critical Care Medicine (2024) Vol. 52, Iss. 3, pp. 509-512
Closed Access
Atorvastatin and telmisartan do not reduce nasopharyngeal carriage of SARS-CoV-2 in mild or moderate COVID-19 in a phase IIb randomized controlled trial
Fabrice Bonnet, Adama Doumbia, Vanessa Machault, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Proteomic Evolution from Acute to Post-COVID-19 Conditions
Yassene Mohammed, Karen Tran, Chris Carlsten, et al.
Journal of Proteome Research (2023) Vol. 23, Iss. 1, pp. 52-70
Open Access | Times Cited: 1
Can Renin-Angiotensin System Inhibitors Protect Against Acute Kidney Injury in Patients With COVID-19?
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
Critical Care Medicine (2022) Vol. 50, Iss. 11, pp. e796-e797
Open Access | Times Cited: 2
The authors reply
Genevieve Rocheleau, Terry Lee, James A. Russell
Critical Care Medicine (2022) Vol. 50, Iss. 11, pp. e797-e798
Open Access | Times Cited: 1
Sex, Renin Angiotensin System Inhibitors, and COVID-19 Severity: Biologic Divergence or Healthcare Disparity?*
Daniel E. Leisman, Emily E. Moin
Critical Care Medicine (2022) Vol. 50, Iss. 9, pp. 1396-1398
Open Access
Different Dimensions of the Effects of SARS-CoV-2 in Causing Fluctuations in the Blood Pressure of Patients
Mahdi Asghari Ozma, Edris Nabizadeh, Mir Reza Valiollahzadeh, et al.
Biointerface Research in Applied Chemistry (2022) Vol. 13, Iss. 4, pp. 377-377
Open Access
Page 1

Scroll to top